国际皮肤性病学杂志    2002 28 (1): 10-13   ISSN: 2096-5540  CN: 32-1880/R   治疗瘢痕药物的研究进展 沈丹蓓, 鞠强, 曹元华, 夏隆庆 中国医学科学院、中国协和医科大学皮肤病研究所 南京 210042 收稿日期 2001-05-16  修回日期 null  网络版发布日期 null 参考文献  [1] Berman B, Duncan MR. Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin. Br J Dermatol, 1990,123(3): 339-346. [2] Berman B, Wietzerbin J, Sanceau J, et al. Pentoxifylline inhibits certain constitutive and tumor necrosis factor-alpha-induced activities of human normal dermal fibroblasts. J Invest Dermatol, 1992,98 (5): 706-712. [3] Dans MJ, Isseroff R. Inhibition of collagen lattice contraction by pentoxifylline and interferon-alpha, -beta, and -gamma. J Invest Dermatol, 1994,102 (1): 118-121. [4] Duncan MR, Hasan A, Berman B. Pentoxifylline, pentifylline, and interferons decrease type Ⅰ and Ⅲ procollagen mRNA levels in dermal fibroblasts: evidence for mediation by nuclear factor 1 down-regulation. J Invest Dermatol, 1995,104(2): 282-286. [5] Wong TW, Lee JY, Sheu HM, et al. Relief of pain and itch associated with keloids on treatment with oxpentifylline. Br J Dermatol, 1999, 140(4): 771-772. [6] Hu D, Hughes MA, Cherry GW. Topical tamoxifen--a potential therapeutic regime in treating excessive dermal scarring? Br J Plast Surg, 1998,51(6): 462-469. [7] Hashimoto M, Inoue S, Ogawa S, et al. Rapid fragmentation of vimentin in human skin fibroblasts exposed to tamoxifen: a possible involvement of caspase-3. Biochem Biophys Res Commun, 1998,247(2): 401-406. [8] Chau D, Mancoll JS, Lee S, et al. Tamoxifen downregulates TGF-beta production in keloid fibroblasts. Ann Plast Surg, 1998,40(5):490-493. [9] Suzawa H, Kikuchi S, Arai N, et al. The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts. Jpn J Pharmacol, 1992,60(2): 91-96. [10] Yamada H, Tajima S, Nishikawa T, et al. Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts. J Biochem (Tokyo), 1994,116(4): 892-897. [11] Shigeki S, Murakami T, Yata N, et al. Treatment of keloid and hypertrophic scars by iontophoretic transdermal delivery of traanilast. Scand J Plast Reconstr Surg Hand Surg, 1997,31 (2): 151-158. [12] Murakami T, Yoshioka M, Yumoto R, et al. Topical delivery of keloid therapeutic drug, tranilast, by combined use of oleic acid and propylene glycol as a penetration enhancer: evaluation by skin microdialysis in rats.J Pharm Pharmacol, 1998,50(1): 49-54. [13] Murad S, Walker LC, Tajima S, et al. Minimum structural requirements for minoxidil inhibition of lysyl hydroxylase in cultuued fibroblasts. Arch Biochem Biophys, 1994,308 (1): 42-47. [14] Parish JL, Hughes MA, Cherry GW, et al. The effect of minoxidil analogues and metabolltes on the contraction of collagen latices by human skin fibroblasts. Br J Plast Surg, 1995,48(3): 154-160. [15] Priestley GC, Aldridge RD, Sime PJ, et al. Skin fibroblast activity in pretibial myxoedema and the effect of octreotide (Sandostatin) in vitro. Br J Dermatol, 1994,131(1): 52-56. [16] Kaneko M, Inoue H, Nakazawa R,et al. Pirfenidone induces intercellular adhesion molecule-1 (ICAM-1) down-regulation on cultured human synovial fibroblasts. Clin Exp Immunol, 1998,113 (1): 72-76. [17] Gurujeyalakshmi G, Hollinger MA, Giri SN. Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fiibrosis at the translational level. Am J Physiol, 1999,276(2 Pt 1): L311-318. [18] Shetlar MR, Shetlar DJ, Bloom RF, et al. Involution of keloid imoplants in athymic mice treated with pirfenidone or with triamcinolone. J Lab Clin Med, 1998,132(6): 491-496. [19] Dolynchuk KN, Ziesmann M, Serletti JM. Topical putrescine (Fibrostat)in treatment of hypertrophic scars: phase Ⅱ study. Plast Reconstr Surg,1996,97(1): 117-123. [20] Shigematsu T, Tajima S, Nishikawa T, et al. Inhibition of collagen hydroxylation by lithospermic acid magnesium salt, a novel compound isolated from Salviac miltiorrhizae Radix. Biochim Biophys Acta, 1994, 1200(1):79-83. [21] Yamada H, Shigematsu T, Tajima S, et al. Screening of potent inhibitors of collagen synthesis in cultured human skin fibroblasts. Arch Dermatol Res, 1995,287(5): 506-508. [22] Baum TM, Busuito MJ. Use of a glycerin-based gel sheeting in scar management. Adv Wound Care, 1998,11 (1): 40-43. [23] Phillips TJ, Gerstein AD, Lordan V. A randomized controlled trial of hydrocolloid dressing in the treatment of hypertrophic scars and keloids. Dermatol Surg, 1996,22 (9): 775-778. [24] Takeuchi M, Tredget EE, Scott PG, et al. The antifibrogenic effects of liposome-encapsulated IFN-alpha2b cream on skin wounds. J Interferon Cytokine Res, 1999,19(12): 1413-1419. [25] Wang X, Smith P, Pu LL,et al. Exogenous transforming growth factor beta(2) modulates collagen Ⅰ and collagen Ⅲ synthesis in proliferative scar xenografts in nude rats. J Surg Res, 1999,87(2): 194-200. [26] Kitzis V, Engrav LiH, Quinn LS. Transient exposure to tumor necrosis factor-alpha inhibits collagen accumulation by cultured hypertrophic scar fibroblasts. J Surg Res, 1999,87(1): 134-141. 通讯作者: